RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort

N/A

Waitlist Available

Led By Amanda L Allen, MD

Research Sponsored by William Beaumont Army Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6, 12, 24 weeks

Summary

A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy with Platelet Rich Plasma versus Extracorporeal Shock Wave Therapy in a High Demand Cohort with Resistant Plantar Fasciitis

Eligible Conditions

Plantar Fasciitis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6, 12, 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6, 12, 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 12, 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Visual analog scale (VAS)

Secondary study objectives

Functional Ankle Ability Measure (FAAM)

Functional Ankle Ability Measure extended sports scale

repeat treatment threshold

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Platelet Rich Plasma Injection GroupExperimental Treatment1 Intervention

shockwave therapy within standard of care using Ossatron system with intervention injection of platelet rich plasma (PRP) using Arthex system, into the plantar fascia at the calcaneal origin

Group II: Placebo injection groupPlacebo Group1 Intervention

shockwave therapy with placebo normal saline injection

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

platelet rich plasma

2014

Completed Phase 4

~760

Do I qualify?Apply below to find out